ID29309A - KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET - Google Patents

KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET

Info

Publication number
ID29309A
ID29309A IDW991574A ID991574A ID29309A ID 29309 A ID29309 A ID 29309A ID W991574 A IDW991574 A ID W991574A ID 991574 A ID991574 A ID 991574A ID 29309 A ID29309 A ID 29309A
Authority
ID
Indonesia
Prior art keywords
trombosis
arterial
inhibitors
prevention
factors
Prior art date
Application number
IDW991574A
Other languages
English (en)
Indonesian (id)
Inventor
Andre Bernat
Jean-Marc Herbert
Maurice Petitou
Ronald Van Amsterdam
Original Assignee
Sanofi Synthelabo Cs
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Cs, Akzo Nobel Nv filed Critical Sanofi Synthelabo Cs
Publication of ID29309A publication Critical patent/ID29309A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW991574A 1997-06-13 1998-06-09 KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET ID29309A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707368A FR2764511B1 (fr) 1997-06-13 1997-06-13 Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire

Publications (1)

Publication Number Publication Date
ID29309A true ID29309A (id) 2001-08-16

Family

ID=9507960

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991574A ID29309A (id) 1997-06-13 1998-06-09 KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET

Country Status (43)

Country Link
US (2) US6541488B1 (is)
EP (1) EP0986376B1 (is)
JP (1) JP3988803B2 (is)
KR (1) KR100598451B1 (is)
CN (1) CN1253150C (is)
AR (1) AR012247A1 (is)
AT (1) ATE384528T1 (is)
AU (1) AU728826B2 (is)
BR (1) BR9810520A (is)
CA (1) CA2293415C (is)
CO (1) CO4940476A1 (is)
CY (1) CY1107912T1 (is)
CZ (1) CZ299518B6 (is)
DE (1) DE69839046T2 (is)
DK (1) DK0986376T3 (is)
DZ (1) DZ2512A1 (is)
EE (1) EE04737B1 (is)
ES (1) ES2299209T3 (is)
FR (1) FR2764511B1 (is)
GT (1) GT199800171A (is)
HK (1) HK1032750A1 (is)
HR (1) HRP980322B1 (is)
HU (1) HU227956B1 (is)
ID (1) ID29309A (is)
IL (1) IL133452A (is)
IS (1) IS2619B (is)
ME (1) ME00685B (is)
MY (1) MY124648A (is)
NO (1) NO323739B1 (is)
NZ (1) NZ501452A (is)
PL (1) PL193405B1 (is)
PT (1) PT986376E (is)
RS (1) RS49902B (is)
RU (1) RU2212886C2 (is)
SA (1) SA98190552B1 (is)
SI (1) SI0986376T1 (is)
SK (1) SK286311B6 (is)
TR (1) TR199903087T2 (is)
TW (1) TW565442B (is)
UA (1) UA70919C2 (is)
UY (1) UY25044A1 (is)
WO (1) WO1998056365A1 (is)
ZA (1) ZA985137B (is)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
US6344450B1 (en) 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
US6297233B1 (en) 1999-02-09 2001-10-02 Bristol-Myers Squibb Company Lactam inhibitors of FXa and method
FR2793687B1 (fr) * 1999-04-26 2001-08-24 Sanofi Sa Nouvelle composition injectable d'un anticoagulant
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
DE60217835D1 (en) * 2001-02-28 2007-03-15 John H Griffin Plasmaglucosylceramiddefizienz als risikofaktor für thrombose und modulator von anticoagulant protein c
UA80399C2 (en) * 2001-11-13 2007-09-25 Glaxo Group Ltd Use of specific dose of fondaparinux sodium for the treatment of acs
AU2003270861A1 (en) 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
EP1564213A4 (en) * 2002-11-22 2009-05-27 Takeda Pharmaceutical IMIDAZOLE DERIVATIVES, PROCESS FOR THE PRODUCTION AND USE THEREOF
JP4855073B2 (ja) * 2003-09-19 2012-01-18 キッセイ薬品工業株式会社 併用医薬
WO2005087266A1 (en) * 2004-03-05 2005-09-22 Vddi Pharmaceuticals Combination therapy for inhibition of platelet aggregation
AU2005236997B2 (en) * 2004-04-23 2010-04-29 Hitoshi Kiya Moving picture data encoding method, decoding method, terminal device for executing them, and bi-directional interactive system
TWI396686B (zh) * 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7563780B1 (en) * 2004-06-18 2009-07-21 Advanced Cardiovascular Systems, Inc. Heparin prodrugs and drug delivery stents formed therefrom
JP5557410B2 (ja) * 2004-07-13 2014-07-23 第一三共株式会社 経口投与による血栓・塞栓の予防治療剤
US20070105825A1 (en) * 2004-09-16 2007-05-10 Yuji Hoyano Concurrent drugs
CA2624867A1 (en) * 2005-10-10 2007-04-19 N.V. Organon Antithrombotic compound
WO2010029552A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
WO2011149110A1 (en) 2010-05-28 2011-12-01 Daiichi Sankyo Company, Limited Novel composition for the prevention and/or treatment of thromboembolism
CA2966249C (en) * 2014-10-30 2019-06-18 Chengdu Baiyu Pharmaceutical Co., Ltd. Pharmaceutical composition containing ginkgolide b and xa factor inhibitor, preparation method thereof and use thereof
CN106860868B (zh) * 2015-12-11 2019-11-22 北京百奥药业有限责任公司 沙班类药物与蚓激酶的药物组合物、制剂及其应用
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548189B1 (fr) * 1983-07-01 1986-04-11 Choay Sa Nouveaux produits contenant des oligosaccharides, leur preparation et leurs applications biologiques et biochimiques
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
FR2728901B1 (fr) * 1994-12-28 1997-03-28 Sanofi Sa Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
IL129877A (en) 1996-11-27 2004-08-31 Aventis Pharm Prod Inc A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire

Also Published As

Publication number Publication date
ZA985137B (en) 1999-01-07
EP0986376A1 (fr) 2000-03-22
EP0986376B1 (fr) 2008-01-23
ATE384528T1 (de) 2008-02-15
KR20010013690A (ko) 2001-02-26
DE69839046D1 (de) 2008-03-13
CA2293415C (en) 2011-08-09
US6541488B1 (en) 2003-04-01
SK170999A3 (en) 2000-07-11
KR100598451B1 (ko) 2006-07-10
PL337288A1 (en) 2000-08-14
GT199800171A (es) 2000-04-21
ES2299209T3 (es) 2008-05-16
CN1274281A (zh) 2000-11-22
SA98190552B1 (ar) 2006-09-09
AR012247A1 (es) 2000-09-27
JP3988803B2 (ja) 2007-10-10
HUP0002175A1 (hu) 2000-11-28
RU2212886C2 (ru) 2003-09-27
HK1032750A1 (en) 2001-08-03
DK0986376T3 (da) 2008-05-13
PT986376E (pt) 2008-04-01
PL193405B1 (pl) 2007-02-28
SK286311B6 (en) 2008-07-07
WO1998056365A1 (fr) 1998-12-17
UA70919C2 (uk) 2004-11-15
FR2764511A1 (fr) 1998-12-18
FR2764511B1 (fr) 2000-09-08
CN1253150C (zh) 2006-04-26
HUP0002175A3 (en) 2003-05-28
CO4940476A1 (es) 2000-07-24
UY25044A1 (es) 2000-10-31
IL133452A0 (en) 2001-04-30
ME00685B (me) 2008-08-07
NO996137D0 (no) 1999-12-10
CZ299518B6 (cs) 2008-08-20
IS5280A (is) 1999-11-30
TW565442B (en) 2003-12-11
IL133452A (en) 2004-09-27
BR9810520A (pt) 2000-09-19
CY1107912T1 (el) 2013-09-04
TR199903087T2 (xx) 2000-05-22
DZ2512A1 (fr) 2003-02-01
HU227956B1 (en) 2012-07-30
DE69839046T2 (de) 2009-01-15
JP2002504110A (ja) 2002-02-05
HRP980322A2 (en) 1999-04-30
CZ446099A3 (cs) 2000-04-12
US20040092477A1 (en) 2004-05-13
NO996137L (no) 2000-02-14
NO323739B1 (no) 2007-07-02
YU63699A (sh) 2002-06-19
EE04737B1 (et) 2006-12-15
HRP980322B1 (en) 2003-12-31
NZ501452A (en) 2002-06-28
AU728826B2 (en) 2001-01-18
RS49902B (sr) 2008-08-07
MY124648A (en) 2006-06-30
EE9900574A (et) 2000-08-15
SI0986376T1 (sl) 2008-06-30
CA2293415A1 (en) 1998-12-17
IS2619B (is) 2010-05-15
AU7924698A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
ID29309A (id) KOMPOSISI UNTUK PENGOBATAN DAN PENCEGAHAN TROMBOSIS ARTERIAL DAN PENGGUNAAN INHIBITOR DARI FAKTOR Xa TERSENDIRI DAN/ATAU DALAM KOMBINASI DENGAN BAHAN AGREGASI ANTI-PLATELET
HUP0002686A3 (en) Guanidine mimics as factor xa inhibitors and pharmaceutical compositions containing the same
ID25626A (id) Metoda untuk pembentukan pelapis film dan komposisi pelapisannya
ID17051A (id) Komposisi farmasi yang terdiri dari mirtazapine dan satu atau lebih inhibitor pengambilan kembali serotonin pilihan
ID30322A (id) HETEROSIKLIK YANG MENGANDUNG INHIBITOR BIFENIL aP2 DAN METODANYA
NO975244D0 (no) 5-ring-heterocykluser som inhibitorer av leukocyttadhesjon og VLA-4-antagonister
DE69300548D1 (de) Verbesserungen an und hinsichtlich des Aufbringens von Beschichtungen.
DE69822395D1 (de) Flüssigkristalline harzzusammensetzung und geformte gegenstände
DE69728594D1 (de) Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen
ID27937A (id) Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut
NO975245D0 (no) Heterocykluser som inhibitorer av laukocyttadhesjon og VLA-4-antagonister
DE50004965D1 (de) Inhibitorkomposition zur Stabilisierung von radikalisch polymerisierbaren Substanzen
DE60315303D1 (de) Zweiphasige zusammensetzung enthaltend polydextrose und saccharose
ZA200306488B (en) Benzamides and related inhibitors of factor Xa.
AR027968A1 (es) Una composicion para utilizar en el tratamiento y/o prevencion del sarampion y el uso de dicha composicion para un vehiculo para el tratamiento o prevencion del sarampion
ITMI20000106A0 (it) Composizione che inibisce la formazione di incrostazioni e/o la corrosione
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
ID29547A (id) Metoda dan komposisi untuk pencegahan dan pengobatan tuberkulosis
DE59808699D1 (de) Verwendung von amphiphilen zur dauerhaften verbesserung der klebstoff- und/oder beschichtungs-kompatibilität von polyolefin-basierten formkörpern
EP1194150A4 (en) USE OF NITROXIDES TO Heal Wounds And To Prevent Radiation Damage To Skin
ID26979A (id) Zat pelapis dan penggunaanya
DE69708800D1 (de) Racemische Verbindung und antiferroelektrische Flüssigkristallzusammensetzung
HUP0201729A2 (en) Inhibitors of the integrin alpha v betha 6
DE50006845D1 (de) Schliessfachanordnung zur aufbewahrung und abgabe von gegenständen
AU2001281941A1 (en) Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia